HIV Vaccine Awareness Day 2019 falls on the cusp of a scientific breakthrough.
Prevention Research Funding Report 2017: Investment Slows and Continues to Concentrate in a Few Funders!
A new report issued at this year's HIVR4P conference states that flat and/or reduced funding for HIV/AIDS and other global health issues threatens to roll back progress worldwide.
Get basic information on how vaccines work and answers to many common questions about a vaccine against HIV.
This fact sheet is about research to find preventive vaccines for use by HIV-negative people.
In the Era of Daily PrEP, Feds May Stop Research Funding Gels, Rings, and Douches for HIV Prevention
The effectiveness of pre-exposure prophylaxis has played a role in diverting U.S. funding from microbicide research.
What are microbicides, why do we need them, and what is the status of current microbicide research? This fact sheet answers those questions and more.
Key PointsA preventive HIV vaccine is given to people who do not have HIV, with the goal of preventing HIV infection in the future.There are currently no preventive HIV vaccines approved by the Food and Drug Administration (FDA), but research is un...
A new HIV vaccine candidate has shown over 50% effectiveness in preventing transmission of an HIV-like virus in monkeys, according to a recent animal study.
May 18 marks the 20th anniversary of HIV Vaccine Awareness Day. AVAC is celebrating by hosting a series of webinars to discuss key issues in vaccine research and advocacy.
There has been a lot of recent HIV research around microbicide use as a way to prevent HIV transmission, and some results have been promising. If you're unfamiliar with what microbicides are or you're looking to get yourself up to speed on all the fa...